Skip to content

Research at St Andrews

Old drugs to treat resistant bugs: methicillin-resistant Staphylococcus aureus isolates with mecC are susceptible to a combination of penicillin and clavulanic acid

Research output: Contribution to journalArticle

DOI

Open Access permissions

Open

Author(s)

Xiaoliang Ba, Ewan M. Harrison, Andrew L. Lovering, Nicholas Gleadall, Ruth Zadoks, Julian Parkhill, Sharon J. Peacock, Matthew T. G. Holden, Gavin K. Paterson, Mark A. Holmes

School/Research organisations

Abstract

β-Lactam resistance in methicillin-resistant Staphylococcus aureus (MRSA) is mediated by the expression of an alternative penicillin-binding protein 2a (PBP2a) (encoded by mecA) with a low affinity for β-lactam antibiotics. Recently, a novel variant of mecA, known as mecC, was identified in MRSA isolates from both humans and animals. In this study, we demonstrate that mecC-encoded PBP2c does not mediate resistance to penicillin. Rather, broad-spectrum β-lactam resistance in MRSA strains carrying mecC (mecC-MRSA strains) is mediated by a combination of both PBP2c and the distinct β-lactamase encoded by the blaZ gene of strain LGA251 (blaZLGA251), which is part of mecC-encoding staphylococcal cassette chromosome mec (SCCmec) type XI. We further demonstrate that mecC-MRSA strains are susceptible to the combination of penicillin and the β-lactam inhibitor clavulanic acid in vitro and that the same combination is effective in vivo for the treatment of experimental mecC-MRSA infection in wax moth larvae. Thus, we demonstrate how the distinct biological differences between mecA- and mecC-encoded PBP2a and PBP2c have the potential to be exploited as a novel approach for the treatment of mecC-MRSA infections.
Close

Details

Original languageEnglish
Pages (from-to)7396-7404
Number of pages9
JournalAntimicrobial Agents and Chemotherapy
Volume59
Issue number12
Early online date21 Sep 2015
DOIs
StatePublished - Dec 2015

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Pseudomonas aeruginosa intensive care unit outbreak: winnowing of transmissions with molecular and genomic typing

    Parcell, B. J., Oravcova, K., Pinheiro, M., Holden, M. T. G., Phillips, G., Turton, J. F. & Gillespie, S. H. 8 Dec 2017 In : Journal of Hospital Infection. In press

    Research output: Contribution to journalArticle

  2. Haem-iron plays a key role in the regulation of the Ess/type VII secretion system of Staphylococcus aureus RN6390

    Casabona, M. G., Kneuper, H., Alferes de Lima, D., Harkins, C. P., Zoltner, M., Hjerde, E., Holden, M. T. G. & Palmer, T. 24 Nov 2017 In : Microbiology. Latest Article

    Research output: Contribution to journalArticle

  3. Functional analysis of the EsaB component of the Staphylococcus aureus Type VII secretion system

    Casabona, M. G., Buchanan, G., Zoltner, M., Harkins, C. P., Holden, M. T. G. & Palmer, T. 22 Nov 2017 In : Microbiology. Latest Article, 13 p.

    Research output: Contribution to journalArticle

  4. The genetic diversity of Staphylococcus aureus colonisation in atopic eczema disease flare

    Harkins, C. P., Pettigrew, K. A., Oravcova, K., Gardner, J., Hearn, R., Rice, D., Mather, A. E., Parkhill, J., Brown, S. J., Proby, C. M. & Holden, M. T. Oct 2017 In : Journal of Investigative Dermatology. 137, 10, p. S258-S258 1 p.

    Research output: Contribution to journalAbstract

  5. The micro-evolution and epidemiology of Staphylococcus aureus colonization during atopic eczema disease flare

    Harkins, C. P., Pettigrew, K. A., Oravcová, K., Gardner, J., Hearn, R. M. R., Rice, D., Mather, A. E., Parkhill, J., Brown, S. J., Proby, C. M. & Holden, M. T. G. 23 Sep 2017 In : Journal of Investigative Dermatology. In press

    Research output: Contribution to journalArticle

Related by journal

  1. Pharmacokinetics, tolerability, and bacteriological response of rifampin administered at 600, 900, and 1,200 milligrams daily in patients with pulmonary tuberculosis

    Aarnoutse, R. E., Kibiki, G. S., Reither, K., Semvua, H. H., Haraka, F., Mtabho, C. M., Mpagama, S. G., van den Boogaard, J., Sumari-de Boer, I. M., Magis-Escurra, C., Wattenberg, M., Logger, J. G. M., te Brake, L. H. M., Hoelscher, M., Gillespie, S. H., Colbers, A., Phillips, P. P. J., Plemper van Balen, G., Boeree, M. J. & PanACEA Consortium 1 Nov 2017 In : Antimicrobial Agents and Chemotherapy. 61, 11, e01054-17

    Research output: Contribution to journalArticle

  2. Genetic determinants of the pharmacokinetic variability of rifampin in Malawian adults with pulmonary tuberculosis

    Sloan, D. J., McCallum, A. D., Schipani, A., Egan, D., Mwandumba, H. C., Ward, S. A., Waterhouse, D., Banda, G., Allain, T. J., Owen, A., Khoo, S. H. & Davies, G. R. 1 Jul 2017 In : Antimicrobial Agents and Chemotherapy. 61, 7, 9 p., e00210-17

    Research output: Contribution to journalArticle

  3. Sialic acid-binding protein Sp2CBMTD protects mice against lethal challenge with emerging influenza A (H7N9) virus

    Govorkova, E. A., Baranovich, T., Marathe, B. M., Yang, L., Taylor, M. A., Webster, R. G., Taylor, G. L. & Connaris, H. Mar 2015 In : Antimicrobial Agents and Chemotherapy. 59, 3, p. 1495-1504 10 p.

    Research output: Contribution to journalArticle

  4. A Staphylococcus xylosus Isolate with a new mecC Allotype

    Harrison, E. M., Paterson, G. K., Holden, M. T. G., Morgan, F. J. E., Larsen, A. R., Petersen, A., Leroy, S., De Vliegher, S., Perreten, V., Fox, L. K., Lam, T. J. G. M., Sampimon, O. C., Zadoks, R. N., Peacock, S. J., Parkhill, J. & Holmes, M. A. Mar 2013 In : Antimicrobial Agents and Chemotherapy. 57, 3, p. 1524-1528 5 p.

    Research output: Contribution to journalArticle

ID: 221686621